Fact CheckerSign in

NCT06802939Recruiting

RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography

Source: ClinicalTrials.gov · Last updated 14 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study is an before-after study in the same patient, which enrolled 36 psychiatric patients with refractory auditory hallucinations. The target of patient intervention relies on the results of magnetoencephalography localization. The medication and dosage remain unchanged during the intervention period. The investigators assume that the intervention targets for each auditory hallucination patient are individualized.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
36 (estimated)
First submitted
26 Jan 2025
Start date
5 Feb 2025
Primary completion date
10 Dec 2026
Lead sponsor
Shanghai Mental Health Center
NCT number
NCT06802939

What you commit to

  • Study type: Interventional
  • Planned participants: 36
  • From 5 Feb 2025 to the primary completion date, 10 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Taboo symptoms for rTMS treatment (such as intracranial metal implants)
  • Metal (including orthodontic treatment, dental implants) and tattoos inside the body

Other illness

  • Major physical illnesses (organic lesions such as sensory and motor disorders, neurological disorders, and traumatic brain injury)

Other

  • MECT treatment within the past 3 months
  • Aggressive behavior and an impulse to damage equipment
  • Claustrophobia

Who the study is looking for

  • Clinical diagnosis of schizophrenia
  • Must be able to right-handed
  • Primary school education or above
  • Understand and sign a written informed consent form (jointly signed by the guardian and the participant if under 18 years old)
  • Existence of persistent auditory hallucinations (defined as: taking sufficient antipsychotic medication for at least 6 months, combined with 3 antipsychotic medications still ineffective, and no significant improvement in auditory hallucinations symptoms, with an AHRS score still\>12)

Age in the registry: 13 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shanghai Mental Health Center
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.